Clinical implications of early detection of Alzheimer's disease and related dementias

Current Projects

The following is a list of projects currently taking place in the lab:

Alzheimer’s Biomarker Survey (ABS)

The goal of this project is to identify factors associated with the decision to seek or avoid personal biomarker-disclosing research and the likelihood to experience negative or positive outcomes following disclosure.

Funding source: National Institute on Aging R03 AG062975 – Alzheimer’s disease biomarker disclosure in African Americans and Whites – Personal and programmatic consequences of knowing ATN status

Amyloid Disclosure Study (ADS)

The goal of this project is to build an infrastructure for disclosure of AD-biomarker information and determine the effects of beta-amyloid disclosure on psychosocial measures and participation in healthy lifestyle activities, long-term care planning, and research study participation.

Funding source: National Institute on Aging Supplement to The Longitudinal Course of Imaging Biomarkers in People at Risk of AD (R01 AG021155)

Assessing Memory with Mobile Devices

The goal of this study is to investigate easily-disseminable, cognitive-based tools for detection of preclinical Alzheimer’s disease (AD). The purpose of this pilot study is to determine the feasibility, reliability, and validity of collecting frequent and remote cognitive data in middle-aged and older adults using hippocampal-based cognitive neuroscience tasks via a mobile device.

Validating Teleneuropsychology for Earlier Dementia Diagnosis

The goal of this project is to determine the feasibility, reliability and validity of direct-to-home teleneuropsychological assessment and unsupervised computerized cognitive testing approaches in the diagnosis of mild cognitive impairment and dementia compared to traditional face-to-face evaluation. Funding source: Wisconsin Alzheimer’s Disease Reserach Center REC scholar program

Listen In: Dr. Clark discusses research updates on Dementia Matters